Literature DB >> 22252183

Reversal of Hartmann's procedure: experience in an Asian population.

W S Tan1, J F Lim, C L Tang, K W Eu.   

Abstract

INTRODUCTION: With improvements in surgical techniques, instrumentation and perioperative care, Hartmann's procedure is now less frequently performed. Restoration of intestinal continuity after Hartmann's procedure has traditionally been viewed to be technically demanding and associated with significant morbidity and mortality. This is a study of outcomes after the reversal of Hartmann's procedure in an Asian population.
METHODS: A prospectively collected database showed that 255 patients had undergone Hartmann's procedure from October 1989 to October 2005. Patients who subsequently underwent Hartmann's reversal were identified and their records reviewed retrospectively.
RESULTS: Hartmann's reversal was attempted in 49 patients. The most common indication for Hartmann's procedure was colorectal carcinoma (49.0%). The median interval between resection and reversal was 23 weeks. Reversal was successful in 46 (93.9%) patients, with 79.6% experiencing no intraoperative complications. Failure of reversal was significantly associated with prior radiotherapy to the pelvis (p-value = 0.007). Anastomotic leak rates and re-bleeding rates were both 0.0%. 79.6% of patients made an uneventful recovery with no postoperative complications. There was no significant increase in the complication rate in older patients or patients with higher American Society of Anesthesiologists status. The overall incidence of 30-day morbidity and mortality was 20.4% and 0.0%, respectively.
CONCLUSION: In our population, Hartmann's procedure is more commonly performed for colorectal cancer rather than for diverticular disease, resulting in lower rates of stoma reversal. Hartmann's reversal could be performed with acceptable morbidity and minimal mortality, although prior radiotherapy and shorter rectal stump may pose challenges during reversal surgery.

Entities:  

Mesh:

Year:  2012        PMID: 22252183

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  8 in total

Review 1.  Reversal of Hartmann's procedure: still a complicated operation.

Authors:  N Horesh; Y Rudnicki; Y Dreznik; A P Zbar; M Gutman; O Zmora; D Rosin
Journal:  Tech Coloproctol       Date:  2017-12-04       Impact factor: 3.781

2.  Hartmann's reversal: factors affecting complications and outcomes.

Authors:  Stewart Whitney; Benjamin D Gross; Alex Mui; Sue Hahn; Blake Read; Joel Bauer
Journal:  Int J Colorectal Dis       Date:  2020-06-05       Impact factor: 2.571

3.  Hartmann's procedure, reversal and rate of stoma-free survival.

Authors:  S Hallam; B S Mothe; Rmr Tirumulaju
Journal:  Ann R Coll Surg Engl       Date:  2018-02-27       Impact factor: 1.891

4.  Intestinal stoma in patients with colorectal cancer from the perspective of 20-year period of clinical observation.

Authors:  Zbigniew Banaszkiewicz; Łukasz P Woda; Tomasz Zwoliński; Krzysztof Tojek; Paweł Jarmocik; Arkadiusz Jawień
Journal:  Prz Gastroenterol       Date:  2015-02-13

5.  A comparative study between open versus laparoscopic Hartmann reversal: A single-center experience and analysis.

Authors:  Hye Jung Cho; Woo Ram Kim; Jong Woo Kim
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

6.  Successful reversal of ostomy 13 years after Hartmann procedure in a patient with colon cancer: A case report.

Authors:  Wang Huang; Zhen-Zhou Chen; Zheng-Qiang Wei
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

7.  Morbidity after reversal of Hartmann operation: retrospective analysis of 56 patients.

Authors:  E C Zarnescu Vasiliu; N O Zarnescu; R Costea; L Rahau; S Neagu
Journal:  J Med Life       Date:  2015 Oct-Dec

8.  A new spray-type adhesion barrier (AdSpray) improves condition for surgical treatment in the reversal of Hartmann procedure: A case report.

Authors:  Wataru Osumi; Masashi Yamamoto; Shinsuke Masubuchi; Hiroki Hamamoto; Masatsugu Ishii; Keisuke Izuhara; Kohei Taniguchi; Toru Kuramoto; Yusuke Suzuki; Keitaro Tanaka; Junji Okuda; Kazuhisa Uchiyama
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.